Reporting owner · CIK 0002048467

Jones Christy

Visual SEC Form 4 history across 1 companies, 5 transactions and 4 filings.

DIRBeta Bionics, Inc.
Open-market mix
Filings4Form 4 records
Buying$00 purchases
Selling$187.2K2 sales
Net value−$187.2KBuys minus sells
Companies12 securities
Most recentSep 22, 2026sale

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Disclosed ownership

How reported shareholdings evolved

Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.

3 observations · Jan 13, 2026Sep 22, 2026. Window ends at the latest available report, not today.

Selected observation · Sep 22, 202619,564 shares reported
Inspect transaction
View exact observations and source transactions
Transaction dateShares held afterFiledSource
Jan 13, 202615,244Jan 15, 2026View transaction
Jun 4, 202627,400Jun 5, 2026View transaction
Sep 22, 202619,564Sep 23, 2026View transaction

Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-5Jan 25Jan 261Jun 261Sep 26

Net value flow

Buys minus sells

Jan 25
$0
Jan 26
$0
Jun 26
−$39.4K
Sep 26
−$147.9K

Transaction texture

Ownership and ticket size

Average P/S size$93.6K
Median P/S size$93.6K
Direct5
Indirect0
Sep 22, 2026sale

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at Beta Bionics, Inc. on Sep 22, 2026 valued at $147,890.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at Beta Bionics, Inc. on Sep 22, 2026 valued at $147,890.

Review SEC filing

Associated companies

Visual map of known reporting history

Latest insider transactions

Form 4 filings from available history. Click any column to sort; click it again to flip the order.

Jones Christy transactions
IDTickerInsiderRoleTypeSharesValueCodeFiledTrans date
#228560BBNXJones Christy
DIR
sale10b5-16.43k-$14.7MS09/2309/22
#99840BBNXJones Christy
DIR
sale10b5-12.81k-$3.93MS06/0506/04
#112815BBNXJones Christy
DIR
grant3.99k$0A01/1501/13
#68496BBNXJones Christy
DIR
grant48.7k$0A02/04/202501/31/2025
#68494BBNXJones Christy
DIR
grant9.13k$0A02/04/202501/31/2025

Jones Christy Insider Activity FAQ

SEC Form 4 context

Who is Jones Christy?

Jones Christy is a reporting owner in SEC Form 4 filings with reporting owner CIK 0002048467.

Which companies has Jones Christy reported transactions for?

Beta Bionics, Inc.

When was Jones Christy's latest insider buy?

No open-market insider purchase is available for this period.

When was Jones Christy's latest insider sale?

sale at Beta Bionics, Inc. on Sep 22, 2026 valued at $147,890.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.